Author

Frederik Nevens 1

1 UZ Leuven,Leuven,Belgium

AUTOSOMAL DOMINANT POLYCYSTIC LIVER DISEASE IS A RISK FACTOR TO HAVE A LARGER LIVER VOLUME COMPARED WITH PATIENTS WITH COMBINED POLYCYSTIC LIVER DISEASE AND AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: RESULTS OF THE PLD REGISTRY

René van Aerts, Michiel de Jong, Wietske Kievit, Frederik Nevens, Hyunsuk Kim, Curie Ahn, Joost P.H. Drenth

CLINICAL IMPLICATION OF THE GLOBE SCORE – AN ACCURATE RISK STRATIFICATION TOOL IN URSODEOXYCHOLIC ACID TREATED PATIENTS WITH PRIMARY BILIARY CIRRHOSIS (PBC) – THE GLOBAL PBC STUDY GROUP

Willem J. Lammers, Gideon Hirschfield, Christophe Corpechot, Frederik Nevens, Keith D. Lindor, Harry L.A. Janssen, Annarosa Floreani, Marlyn J. Mayo, Pietro Invernizzi, Pier M. Battezzati, Albert Pares, Andrew K. Burroughs, Andrew L. Mason, Kris V. Kowdley, Teru Kumagi, Maren H. Harms, Palak J. Trivedi, Raoul Poupon, Ange

DRUG HOLIDAY IN PATIENTS WITH POLYCYSTIC LIVER DISEASE TREATED WITH SOMATOSTATIN ANALOGUES: A NOVEL TREATMENT STRATEGY

René M.M. van Aerts, Marieke Kolkman, Wietske Kievit, Tom Johannes Gerardus Gevers, Frederik Nevens, Joost P.H. Drenth

DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 18 MONTHS OF OPEN-LABEL LONG-TERM SAFETY EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS

Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone Strasser, Christopher L. Bowlus, Pietro Invernizzi, Joost P.H. Drenth, Paul Pockros, Jaroslaw Regula, Annarosa Floreani, Simon Hohenester, Velimir Luketic, Mitchell Shiffman, Karel van Erpecum, Victor Vargas, Catherine Vincent, Bettina E. Hansen;;

DURABLE RESPONSE IN THE MARKERS OF CHOLESTASIS THROUGH 24 MONTHS OF OPEN-LABEL EXTENSION STUDY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS

Michael Trauner, Frederik Nevens, Pietro Andreone, Giuseppe Mazzella, Simone Strasser, Pietro Invernizzi, Joost P.H. Drenth, Paul Pockros, Jaroslaw Regula, Annarosa Floreani, Simon Hohenester, Velimir Luketic, Mitchell Shiffman, Karel van Erpecum, Victor Vargas, Catherine Vincent, Bettina E. Hansen, Christopher L. Bowlus;;

EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure

Julia Wendon, Juan Cordoba, Anil Dhawan, Fin Stolze Larsen, Michael Manns, Frederik Nevens, Didier Samuel, K.J. Simpson, Yaron Ilan, Mauro Bernardi

EFFICACY OF OBETICHOLIC ACID IN THE TREATMENT OF PRIMARY BILIARY CIRRHOSIS BY CONTINENTAL REGIONS

Velimir Luketic, Pietro Andreone, Frederik Nevens, Janet Owens-Grillo, Richard Pencek, Tonya Marmon, Leigh MacConell

ELEVATED ALKALINE PHOSPHATASE IS AN INDEPENDENT PREDICTOR OF GOOD RESPONSE DURING SOMATOSTATIN ANALOGUE THERAPY: A MULTI-CENTER POOLED ANALYSIS ON INDIVIDUAL PATIENT DATA

Tom Johannes Gerardus Gevers, Frederik Nevens, Vicente Torres, Marie C. Hogan

ESTIMATED ANNUAL LIVER GROWTH PREDICTS NEED FOR TREATMENT IN POLYCYSTIC LIVER DISEASE

Thijs Barten, Lucas H.P. Bernts, Sophie Aapkes, Ron Gansevoort, Curie Ahn, Frederik Nevens, Joost P.H. Drenth, Tom Gevers

Management of difficult patients with primary biliary cholangitis (PBC)

Frederik Nevens

Item 1 - 10 / 15
1
2